Dr. George A. Fisher Jr., MD

Dr. Fisher practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Fisher's NPI, 1255446308, was assigned on August 20, 2006. Dr. Fisher graduated from Stanford University School Of Medicine in 1987. Dr. Fisher holds California license G65330.

Dr. Fisher's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Fisher's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Fisher is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Fisher to 1 more hospital, named with a free account. Dr. Fisher's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fisher practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fisher's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fisher is board certified in medical oncology by the American Board of Internal Medicine. Dr. Fisher is licensed in California.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma and prostate cancer among the conditions Dr. Fisher treats.

CMS data shows 430 Medicare services from Dr. Fisher across 4 procedure codes in 2024, for 201 Medicare patients. Medicare paid $67,068 for them.

CMS counts 201 Medicare patients who saw Dr. Fisher in 2024. The largest group is 65 to 74, with 93 patients. 69% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fisher's median patient age at 62, with 46% women.

In 2024, Dr. Fisher wrote 17 Medicare Part D claims. 76% of them were for generic drugs. They cover 2 drugs, with $11,422 in total drug cost. In 2019, CMS named 112 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fisher for performance year 2024, reported as part of a group. Dr. Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fisher as offering telehealth.

Dmand AI links 124 papers to Dr. Fisher, published from 2005 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Adenocarcinoma. Dr. Fisher has published most often in Int J Radiat Oncol Biol Phys. Dr. Fisher's most frequent co-authors are James Matthew Ford, MD, Albert C. Koong, MD, PhD and Branimir I. Sikic, MD.

Dmand AI links Dr. Fisher to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Gastrinoma and Glucagonoma.

CMS Open Payments shows 192 general payments to Dr. Fisher from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Merck Sharp & Dohme Corporation paid the most, $117,049.

Dmand AI lists 1 award for Dr. Fisher, most recently CMS Stage 1 EHR in 2013.

Dr. Fisher graduated from Stanford University School Of Medicine in 1987.

Dr. Fisher is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.